Key Metrics
CiteScore 

6.1
Eigenfactor 

0.005 - 0.01
H-Index 

84
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.83
Recommended pre-submission checks
Powered by 

Topics Covered on Future Medicinal Chemistry
Future Medicinal Chemistry Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | NEWLANDS PRESS LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Future Medicinal Chemistry ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Future Medicinal Chemistry
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches.
- 19 May 2026
- Future medicinal chemistry
Ultrasound-assisted 1,2,4-triazole Schiff bases: synthesis, characterization, docking, and dual inhibition of urease and α-glucosidase.
- 19 May 2026
- Future medicinal chemistry
Targeting traumatic brain injury via novel tetrahydrocarbazole derivatives: in silico design, synthesis, and in vitro evaluation of dual NADPH oxidase 2 and 4 inhibitors.
- 14 May 2026
- Future medicinal chemistry
Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.
- 11 May 2026
- Future medicinal chemistry
Synthesis of 2, 4-disubstituted-1H-benzo[b][1,4]diazepine derivatives as promising anticancer agents.
- 9 May 2026
- Future medicinal chemistry
Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations.
- 6 May 2026
- Future medicinal chemistry
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches.
- 19 May 2026
- Future medicinal chemistry
Ultrasound-assisted 1,2,4-triazole Schiff bases: synthesis, characterization, docking, and dual inhibition of urease and α-glucosidase.
- 19 May 2026
- Future medicinal chemistry
Targeting traumatic brain injury via novel tetrahydrocarbazole derivatives: in silico design, synthesis, and in vitro evaluation of dual NADPH oxidase 2 and 4 inhibitors.
- 14 May 2026
- Future medicinal chemistry
Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.
- 11 May 2026
- Future medicinal chemistry
Synthesis of 2, 4-disubstituted-1H-benzo[b][1,4]diazepine derivatives as promising anticancer agents.
- 9 May 2026
- Future medicinal chemistry
Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations.
- 6 May 2026
- Future medicinal chemistry